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An analysis of 71 cases.




Periprosthetic fractures of the proximal femur are difficult fractures to treat,
especially in the compromised geriatric patient. High rates of complications
have been reported in literature. Few series report a large number of patients
combined clinical results.
Purpose
The purpose of this study was to determine the clinical results of treatment of
periprosthetic fractures in an observational study.
Materials and Methods
The medical records of patients treated for a periprosthetic fracture between
1993 and 2006 were obtained. Radiographic evaluation was performed
according to the Vancouver classification. Patients were contacted to obtain
an Oxford Hip Score. Statistical analysis was performed with SPSS 14.0.
Results
For 71 patients with 71 fractures, medical records and radiographs were
available. Mean age at time of fracture was 73.4 years (38-95). The mean
time between primary operation and fracture was 6.3 years. 44 fractures
occurred in patients with primary hip arthroplasty (62%) and 27 fractures
developed in patients with revision implants (38%). 11 patients (15.5%)
suffered from major systemic complications, defined as life-threatening
events. 34 patients (48%) suffered from a complication, leading to a re-
operation in 22 cases (33%). The most frequent indication for re-operation
was re-fracture or implant failure. Noteworthy Vancouver type C fractures
lead to re-operations in 52% of the cases (11 of 20).
36 patients (51%) were able to complete an Oxford Hip Score after a
mean period of 64.9 months (16-157). The other patients were tracked and
confirmed lost to follow up (death 45%, mentally impaired 4%). Mean
Oxford score was 27.8 (12-57) and significantly higher in patients suffering
from a complication (p=0.02) and in patients with a fracture after revision
surgery (p=0.02).
Conclusion
The treatment of periprosthetic femoral fractures has a high complication rate
and number of re-operations. Long term clinical results are compromised by




Total hip arthroplasty(THA) is among the most successful operative
procedures known to medicine. The prevalence is rapidly increasing due to
its success. However, with the success also the downside becomes
increasingly important: the complications associated with total hip
arthroplasty. Although the number of serious complications on the long term
is low, a serious complication is the periprosthetic fracture (PPF) of the femur.
Often, these fractures occur in older, compromised patients, raising mortality
rates.1 The increase in number of patients treated with THA, as well as
people getting older, create a large population “at risk”. In literature the
increasing incidence of PPF has been reported by a number of study
groups.2,3
Several retrospective studies are published, however with limited
information on clinical outcomes.4-8 Using the Swedish Arthroplasty
Register, Lindahl et al. were able to report a large prospective series and
identify risk factors for PPF (e.g. stem design).6 Their patients showed an
impaired hip function and low health status derived from questionnaires at
follow up.
We performed a retrospective study in two hospitals and included the
Oxford Hip Score hip score questionnaire 12 and a review of the complete
radiologic follow up. According to clinical observations and literature reports
we expected high major complication rates especially re-operations.
Osteosynthesis performed for Vancouver type B fractures were expected to
have a high failure rate as previously described in literature reports. We
posed the following research questions: Does the treated PPF population
show a high complication rate? Do these patients show an impaired
functional outcome and is this influenced by the method of treatment?
Materials and Methods
The medical records and radiographs of all patients with a PPF between
March 1992 and February 2006 were collected from the registers of the
University Medical Centre Groningen and the Martini Hospital, both situated
in Groningen, The Netherlands. Eighty patients were identified with eighty
periprosthetic fractures of the femur. The patient’s mobility in the period prior
to the fracture and after fracture healing was described on the basis of
clinical notes in the medical records. Co-morbidity was described and
categorised.
The trauma mechanism was divided into minor trauma, which was
defined as a low energy trauma resembling a simple fall to the floor, major
trauma; high energy trauma for example a traffic accident or fall from a
height and spontaneous fracture in cases where no clear trauma mechanism
could be identified. Fractures were classified according to the Vancouver
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classification system5,9, which integrates the site of the fracture, the stability
of the implant and the quality of host bone stock. Type-A fractures are
trochanteric, either greater (Ag), or lesser (Al). Type-B fractures occur around
the stem of the prosthesis or just below it. Type-B1 incorporates fractures in
with a solidly fixed implant. In Type-B2 and B3 the femoral component is
loose. In Type-B3 is severe bone stock loss as well. Type-C fractures occur
well below the tip of the stem. Fractures were classified by authors according
to the radiographs and operative reports. Indication for initial arthroplasty
was assessed as well as the number of operations prior to the fracture.
Treatment of fractures was categorised as non-operative, revision, femur-nail
or open reduction and internal fixation (ORIF). ORIF was subdivided into
plate-screw fixation, cable-grip plate, cerclages, or a combination of the
above treatment modalities. The duration of hospitalisation was also
recorded. Complications were reviewed and categorised in femur related
complications (re-fracture within one year, non-union and dislocation) The
complications were subcategorised according to Parvizi et al.10 Major
systemic complications were deemed to be life-threatening and required
complex medical intervention, such as transfer to the intensive care unit.
Major local complications necessitated additional surgical intervention or
were deemed to result in temporary or permanent functional impairment.
Minor systemic or local complications (urinary tract infection, pneumonia,
decubitus) required longer hospital stay or medicinal treatment.11 Patients
were contacted to complete the Oxford Hip score, a questionnaire
containing twelve items developed to measure the outcome of total hip
replacement surgery (each item is scored 1 to 5, from least to most difficulty
or severity).12,13 A high score represents an impaired function. Clinical notes
from medical records concerning mobility one year after surgery were
obtained for deceased patients at the time of follow-up.
Statistical analysis was performed on a personal computer using SPSS for
Windows XP (version 14.0). A p<0.05 was considered significant.
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Type A # Type B1, B2 and B3 # Type C #
Results
Patient, Fracture and Implant characteristics
Seventy-nine patients were identified with eighty periprosthetic fractures.
Only in seventy-one cases of PPF radiographs were available for Vancouver
classification due to destroyed radiographs by hospital administration. These
patients (52 female (72%) had a mean age of 73.4 years (range 38 to 95).
Mean implant survival at time of fracture was 6.3 years. At the time of final
follow-up 32 (45%) patients had deceased, one had migrated and two were
unable to answer the questionnaire because of impaired mental status. The
mean radiological follow up was 3 years (3 months to 12.8 years).
Reasons for initial total hip replacement surgery were osteoarthritis
(70%), fracture (16%), secondary arthritis (9%) and a-vascular necrosis of the
femoral head (5%). Fifty-eight percent of the patients had one or more co-
morbidities. Twenty-seven (38%) fractures occurred in patients with at least
one revision arthroplasty and forty-four (62%) after a primary total hip
replacement. The majority of the periprosthetic fractures were caused by
minor trauma (87%) followed by spontaneous fractures (9%) and major
trauma (4%). 62 patients (87%) had a cemented implant, 9 patients (13%)
had an uncemented hip stem prior to fracture. Patients characteristics are
given in Table 1 and 2.
Primary versus revision treatment
27 cases of PPF occurred in patients who had a history of revision
arthroplasty. Of the 44 patients with PPF after primary THA, 70.5% (n=31)
had a type B fracture and 25% (n=11) a type C. The revision group (n=27)
showed a type B fracture in 59.2% (n=16) and a type C fracture in 37%
(n=10). This difference was not significant (p>0.05).
The primary group had their prostheses significantly longer in situ than
the revision group, 7.8 years vs. 3.9 years (p<0.05). The mean age in the
primary group was not significantly different from the revision group, 73.3
years (44 patients) vs. 73.6 years (27 patients) (p>0.05).
Clinical results
From both groups (primary and revision group) 35 patients (49%) were able
to fill in a complete Oxford Hip Score after a mean period of 64.9 months
(16-157). The average Oxford Hip Score outcome was 27.8 points (range 12-
57). A high score implicates a bad function. A significant difference was
found between the mean Oxford score of the patients with a primary total
hip replacement (24.3 points) and patient with multiple implants before
fracture (33.8 points) (p=0.02). Patients suffering from a femur-related
complication scored significantly worse on the hip score at long term follow
up (p=0.02). No significant difference in hip score outcome was found
between various operative techniques. Of the patients that had no Oxford
score (death 45%, mentally impaired 4%), half of them returned to
preoperative mobilisation levels according to the medical records.
59
High incidence of complications and poor patient outcome
60
Chapter 5
Table 1. Patients with periprosthetic fractures after primary total hip replacement.
Age Sex Indication Implant type Implant survival Trauma
80 M OA Stanmore 1/12 No
82 F OA Stanmore 16 1/4 No
79 M OA Stanmore 23 1/4 No
60 M OA Mallory-Head 1 7/12 min
80 M OA Stanmore 12 5/12 min
85 F OA SHP 5 5/12 min
93 F OA Mc Kee Ferrar 15 1/4 min
57 M OA SHP 1 min
64 M OA SHP 3 2/3 min
61 F OA Judet 11 5/12 min
78 F OA SHP 2 1/6 min
72 F OA SHP 4 11/12 min
72 F OA SHP 3/4 min
75 F OA SHP 4 5/12 min
79 F OA Stanmore 14 1/12 min
90 F OA Harris Monoblock 14 1/12 min
81 F OA SP 11 5/6 min
81 F OA Harris Monoblock 10 1/2 min
64 M OA SHP 3 1/4 min
87 F OA Mc Kee Ferrar 23 2/3 min
64 F OA SHP 1 1/12 min
68 F OA SHP 3/4 min
80 M OA Stanmore 15 5/12 min
83 M OA Stanmore 13 1/12 min
84 F OA Stanmore 5 1/12 min
83 F OA Stanmore 1 1/3 min
95 F OA Monoblock Muller 7 1/3 min
81 F OA SHP 5 5/6 min
61 F OA SHP 5/12 min
39 M RA SP 16 1/12 min
67 M RA Proplast 17 1/4 min
64 M RA SHP 1 1/3 min
77 F OA Harris Monoblock 13 11/12 min
86 F Fx Monoblock Muller 6 1/2 min
85 F Fx Zweimuller 6 1/4 min
89 F Fx Stanmore 7 11/12 min
87 F Fx Stanmore 10 1/12 min
84 F Fx Stanmore 7 1/4 min
57 F OA Mallory-Head 1/12 min
50 F OA Mallory-Head 1/12 min
69 M OA SP 13 3/4 min
47 F AVN Harris Monoblock 11 1/12 min
59 M OA SHP 2 1/4 maj
48 F AVN Mallory-Head 1/12 maj
OA=primairy osteoarthritis, RA= rheumatoid arthritis, Fx=fracture, AVN=avascular necrosis of the femoral head,
min=minor trauma, maj=major trauma, no= no obvious trauma, Min C = Minor complication,
Maj C=Major complication, Fem C=femoral related complication, N/A=not available
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Vancouver Treatment Complication Reoperation Patient deceased Oxford
Type B1 ORIF Maj C No alive N/A
Type B1 ORIF Maj C No 3 mnd N/A
Type B3 other No No within 5 years N/A
Type B1 ORIF No No alive 12
Type B1 ORIF No No within 2 years N/A
Type B1 ORIF No No alive 31
Type B1 ORIF No No > 5 years N/A
Type B2 Revision No No alive 20
Type B2 Revision Fem C Yes alive 39
Type B2 Revision No No within 5 years N/A
Type B2 ORIF Min C Yes within 5 years N/A
Type B2 Revision Min C No alive 34
Type B2 Revision + ORIF No No alive N/A
Type B2 Revision + ORIF No No alive 42
Type B2 Revision + ORIF No No > 5 years N/A
Type B2 Revision Min C No within 2 years N/A
Type B2 Revision + ORIF No No alive 19
Type B2 Revision No No alive 18
Type B3 Revision No No alive 39
Type B3 Revision + ORIF Min C No within 2 years N/A
Type C ORIF No Yes alive 12
Type C ORIF No Yes alive 15
Type C ORIF Min C Yes > 5 years N/A
Type C ORIF Maj C No within 3 mnd N/A
Type C ORIF No No within 5 years N/A
Type C ORIF No No within 5 years N/A
Type C ORIF No No within 5 years N/A
Type B2 Revision + ORIF No No alive 29
Type C ORIF No No alive 26
Type A g Revision + ORIF No No alive 29
Type B2 Revision + ORIF Maj C No alive 15
Type C ORIF Fem C Yes alive 18
Type B2 Revision + ORIF Fem C Yes within 1 year N/A
Type B2 Revision + ORIF Maj C Yes within 1 year N/A
Type B2 Revision + ORIF Fem C Yes alive 31
Type B3 Revision No No within 5 years N/A
Type C ORIF Fem C Yes > 5 years N/A
Type C ORIF Fem C Yes within 2 years N/A
Type A l Revision + ORIF No No within 5 years N/A
Type B2 ORIF No No alive 18
Type B3 Revision + ORIF Min C Yes alive 25
Type B2 Revision Maj C Yes alive 34
Type B2 ORIF Maj C No alive 17
Type B1 ORIF No No alive 12
Fracture treatment
The various treatments used for the fractures are shown in Table 3.
Vancouver B2 and B3 fractures underwent revision arthroplasty with or
without the use of additional internal fixation in seventy-six percent (25 out
of 33) of the cases. One patient received an intramedullary osteosynthesis
and one patient was considered not fit for operation and therefore treated
conservative. The rest was treated with ORIF (18%). Vancouver type C
fractures where treated with ORIF in ninety-five percent (20) of the cases.
At six months postoperative fracture consolidation was evaluated of the
surviving patients (n=66). 35 fractures showed consolidation, 20 patients
lacked signs of fracture union. In 11 patients no reliable judgement could be
made due to implant overlay.
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Table 2. Patients with periprosthetic fractures after revision surgery
Age Sex Indication Implant type Implant survival Trauma
82 Man OA Stanmore 8 3/5 no
69 Woman SA Mallory-Head 2/3 no
92 Woman Fx Stanmore 12 5/6 no
57 Woman OA Stanmore 13 3/5 Min
87 Woman OA Stanmore 8 1/3 Min
63 Woman OA Exeter 7 Min
82 Man OA Stanmore 10 5/6 Min
81 Woman OA Stanmore 6 2/3 Min
81 Woman OA SHP 3/5 Min
76 Man OA Exeter 0 Min
74 Woman OA SHP 2 Min
74 Woman OA Exeter 1/3 Min
79 Woman OA Stanmore 0 Min
82 Woman OA Stanmore 3 Min
67 Woman OA Exeter 1/3 Min
38 Woman SA Exeter 1/2 Min
39 Woman AVN Mallory-Head 0 Min
77 Woman Fx Kalcar 1/4 Min
87 Woman Fx Muller 1 1/6 Min
69 Woman Fx SP 5 Min
74 Woman Fx Stanmore 9 1/6 Min
71 Woman Fx Charnley 4 2/3 Min
89 Woman OA SHP 7 1/6 Min
86 Woman OA Exeter 0 Min
91 Man OA Exeter 0 Min
56 Woman SA Exeter 1 Min
64 Man AVN SP 1/2 Maj
OA=primairy OA, SA= secondairy osteoarthritis, RA= rheumatoid arthritis, Fx=fracture, AVN=avascular necrosis of the
femoral head, min=Minor trauma, maj=Major trauma, no= no obvious trauma, Cons=conservative,
Min C = Minor complication, Maj C= Major complication, Fem C=femoral related complication, N/A=not available
Chapter 5
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Vancouver Treatment Complication Reoperation Patient deceased Oxford
Type B3 Revision No No > 5 years N/A
Type B1 nail Fem C Yes > 5 years N/A
Type B3 nail Fem C No within 5 years N/A
Type B1 ORIF Min C No within 5 years N/A
Type B1 Cons No No within 6 mnd N/A
Type B2 ORIF Fem C Yes Alive 26
Type B2 ORIF Min C No Alive 34
Type B2 Revision Maj C No within 3 mnd N/A
Type B2 ORIF No No Alive N/A
Type C ORIF Min C Yes within 2 years N/A
Type C ORIF Fem C Yes alive 54
Type C ORIF No No alive 18
Type C nail No No > 5 years N/A
Type C ORIF Maj C Yes alive 44
Type C ORIF Min C No alive 29
Type C ORIF No Yes alive N/A
Type A g Cons No No alive 48
Type B1 Cons Fem C No > 5 years N/A
Type B1 ORIF No No alive 25
Type B2 Revision Min C Yes alive 20
Type B2 Revision No No > 5 years N/A
Type C ORIF No No alive 22
Type B2 Revision No No alive 31
Type C ORIF No No within 5 years N/A
Type C ORIF Maj C Yes alive 31
Type B1 ORIF Fem C Yes alive 57
Type B1 Revision Maj C No within 3 mnd N/A
Table 3: The overview of various treatments in relation to the Vancouver fracture type.
ORIF Revision Revision arthroplasty Other Total
arthroplasty and ORIF
Vancouver A 0 0 2 1 3
Vancouver B1 10 1 0 3 14
Vancouver B2 6 10 10 0 26
Vancouver B3 0 3 2 2 7
Vancouver C 20 0 0 1 21
Total 36 14 14 7 71
Complications
11 patients (15.5%) suffered from major systemic complications. Four
patients (5.6%) died within three months after treatment. Additionally seven
patients (9.8%) died within one year after treatment. Minor systemic
complications were noted in 11 patients (15.5%).
Thirty-two percent of all patients (n=23) were re-operated one or more
times after fracture treatment, twenty-one percent (n=21) within one year.
Table 4 shows re-operations in relation to primary treatment. Nine patients
needed more than one intervention. The most common indication for re-
operation was re-fracture or implant failure (44%), followed by infection of
the prosthesis (26%), non-union (17%), dislocation (9%) and a-septic
loosening of the stem (4%).
8 out of the initially 26 patients (31%) with a Vancouver B2 fracture were
re-operated for pseudarthrosis, plate breakage or infection. 55% of the
patients with a Vancouver type C fracture underwent a re-operation after
ORIF (11 of 20). Open reduction and internal fixation resulted in a
significantly higher rate of re-operations than revision surgery with or
without the open reduction and internal fixation (p=0.02) in the Vancouver B
fractures. Patients with a complication had a significant longer duration of
hospitalisation (p=0.02).
Discussion
Treatment of periprosthetic fractures after a total hip replacement is complex
and high complication rates are reported in literature. In our series we
encountered a considerable number of serious complications. Considering
to the variety of treatment modalities used we were not able to establish
differences between these forms of treatment due to small groups after
stratification. More re-operations were seen in patients treated with
osteosynthesis than in patients with a revision arthroplasty. More
complications were seen in the Vancouver type C group.
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Table 4. Number of re-operations in relation to the number of treated periprosthetic fractures.
Vancouver classification A (n=3) B1 (n=12) B2 (n=26) B3 (n=6) C (n=21) total
Revision 0 / 0 0 / 0 2 / 10 0 / 3 0 / 0 2
Revision and ORIF 0 / 2 0 / 1 4 / 10 1 / 2 0 / 0 5
ORIF 0 / 1 1 / 10 2 / 6 0 / 0 11 / 20 14
Femoral nail 0 / 0 1 / 1 0 / 0 0 / 2 1 / 1 2
Total per fracture type 0 2 8 1 12 23
The re-operation rate is very high, in concordance with literature reports.14
Not many treatment protocols in fracture surgery show similar high re-
operation rates. Especially in this elderly aged, compromised, patient group,
re-operations are very unwanted and threatening to the patient’s health. This
makes the treatment of PPF both difficult and challenging.
One of the major reasons for re-operation is implant failure. Plate breakage
is often a result of delayed or non-union and progressive load bearing. In our
study only 36 of 67 patients showed clear signs of radiological union at 6
months to the investigators. In 11 patients no reliable judgement could be
made. Implants (e.g. meshes) hindered our (retrospective) radiographic
judgement considering fracture healing. Of this small group 4 out of 11 (36%)
patients were re-operated afterwards. Of the 36 patients with consolidated
fractures only six (16.6%) patients were re-operated. This difference is 20%
and not significant, P=0.15 (Fisher’s exact test mid P). The implant failure may
have been caused by assumption of fracture-consolidation of the treating
physician. The clinical decision of progressive mobilisation and weight bearing
might have caused the implant failure. To prevent misjudgement or
underestimation of fracture union we suggest the use of additional radiographs
in other directions or prolonged protective weight bearing.
The relatively high amount of failure of osteosynthesis raised suspicion of
slower fracture consolidation. Fracture healing depends on biological,
biomechanical or force-loading factors. All of these factors are altered in the
case of a periprosthetic fracture when compared to a femur without prior hip
prosthesis surgery. In the first place the local biological environment might
be influenced by a pre-existent intramedullary implant. Second, soft tissue
damage and disturbed blood supply caused by prior surgery might
contribute to a slower healing process of a periprosthetic fracture. Finally, the
biomechanical properties of a femur with an implant in situ and the
consequences on periprosthetic fracture healing are not known. The
beneficial effect of load bearing on fracture healing is well established by
research. In periprosthetic fracture treatment only revision stems or
retrograde nails bridging the stem can offer sufficient stability and have
immediate weight bearing capacities. Other implants might fail due to
insufficient stability. Long protective weight bearing is commonly practised
in patients with these forms of treatment. However, compliance of the
patient, to obey to non-weight bearing instructions is a major concern in the
geriatric population. It is possible that these patients load their extremity
regardless of the instructions. Further research has to be done on this subject
whether partial weight bearing is possible at all in this patient group.
Periprosthetic fractures in patients with THR for proximal femoral fracture
showed a higher complication rate following their periprosthetic fracture
treatment. Hypothetically the outcome and complications could have been
influenced by the bone quality of these patients. Osteoporosis is at least a
major contributing factor to hip fracture. Screening for osteoporosis in older
patients and treatment is important to prevent fractures. Many patients with
osteoporotic fractures are not treated with bisphosphonates or calcium, thus
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many patients have diminished bone mineral density around the prosthesis
leaving them prone to PPF. The same mechanism can be true for patients
with a revision arthroplasty in the past. Patients with multiple implants before
developing a periprosthetic fracture had shorter implant survival than
primary hip stems with a fracture, possibly as a result of this previously
mentioned poor bone quality. Unfortunately, in our series no bone quality
measurement was made. Nevertheless bone strength should be subject of
further research in periprosthetic fracture prevention and treatment.
In our series, several patients with radiographic signs of loosening were
treated with osteosynthesis. Recently Parvizi et al. proposed an algorithm for
periprosthetic fracture treatment.15 Revision arthroplasty is advised for type
B2 and B3 fractures. In our series six patients with Vancouver B2 fractures
were treated using internal fixation. Two of these patients were re-operated.
Therefore, if the proposed algorithm was applied, better results might have
been obtained.
Furthermore, a remarkable result is the high occurrence of re-operations in
the Vancouver C group treated with ORIF (55%). Possibly the initial stability
of the stem, the influence of the ORIF on fracture healing or the rehabilitation
schedule (especially the load bearing) might be among the reasons. Many
clinicians might use the (after)treatment for the normal femoral fracture,
however this regime might not be favourable in periprosthetic femoral
fractures. Biomechanical factors could play a role in failure scenarios as
hinging of the fracture site or significantly altered off-loading fracture level is
quite possible in the area well below the tip of the stem.
This study combines retrospective results and a prospective hip
questionnaire. The mean Oxford hip score in our series was 27.8 after a
mean period of 64.9 months. This is worse than the reported 20.6-22.6 for
primary and revision hip surgery by Field et al.16 It is expected that people
who were able to complete the questionnaire were likely to have superior
scores compared to the patients who were not. Our patients who underwent
a revision arthroplasty prior to their periprosthetic fracture had a significant
higher Oxford score, implicating a worse functional outcome. These scores
were worse than results reported for regular elective revision arthroplasty.
Patients who suffered from a complication had a higher Oxford score at
long-term follow up. This emphasizes the importance of prevention of
complications and re-operations. The Oxford score is a test validated for hip
function in primary hip arthroplasty. Patients with general physical impairment
have a higher sore as well. This could have affected the results, delivering a
worse overall score. This study however, describes long term results of a patient
group with a specific diagnosis and treatment. Few reports in literature provide
these clinical follow up data. The need for prospective follow-up studies is
imminent for better understanding of fracture healing of periprosthetic femurs.
Treatment algorithms can be adjusted to improve results. Especially if patient-
based and clinician based outcome scores are used to define patients groups
more accurately than just the fracture classification.
In conclusion, this study shows high complication rates and high re-
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operation rates in patients treated for periprosthetic femoral fractures. In
addition to the generally recognised complexity of the treatment of Type B
fractures, the treatment of Vancouver type C fractures deserves more
attention in literature and in clinical practice to prevent re-operations.
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